Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 24,236 |
|
|||||
| News | - | ||||||
| Day High | 14.52 | Low High |
|||||
| Day Low | 13.64 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Greenwich LifeSciences Inc | GLSI | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.01 | -0.07% | 13.99 | 18:57:21 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 14.22 | 13.64 | 14.52 | 13.99 | 14.00 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 677 | 24,236 | US$ 14.06 | US$ 340,649 | - | 7.58 - 21.44 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:57:47 | 1 | US$ 14.46 | USD |
Greenwich LifeSciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 177.43M | 12.85M | - | 0 | -8.89M | -0.69 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Greenwich LifeSciences News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GLSI Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.425 | 14.75 | 11.99 | 13.17 | 32,290 | 1.57 | 12.60% |
| 1 Month | 17.70 | 18.275 | 11.375 | 14.30 | 36,631 | -3.71 | -20.96% |
| 3 Months | 8.43 | 21.44 | 8.15 | 14.64 | 54,937 | 5.56 | 65.95% |
| 6 Months | 8.75 | 21.44 | 8.00 | 13.35 | 35,895 | 5.24 | 59.89% |
| 1 Year | 11.35 | 21.44 | 7.58 | 12.25 | 26,278 | 2.64 | 23.26% |
| 3 Years | 38.16 | 48.96 | 6.8241 | 18.06 | 69,759 | -24.17 | -63.34% |
| 5 Years | 5.00 | 158.07 | 3.262 | 36.94 | 162,363 | 8.99 | 179.80% |
Greenwich LifeSciences Description
| Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in most breast cancers at low, intermediate, and high or overexpressor levels. |
